Rhinitus/Sinusitis/Ocular Allergy News

Extended use of omalizumab up to 1 year showed efficacy for the treatment of uncontrolled chronic rhinosinusitis with nasal polyps, according to long-term results published in The Journal of Allergy and Clinical Immunology.

Benralizumab appeared effective for severe eosinophilic asthma in a real-world study of patients with and without chronic rhinosinusitis with nasal polyps, according to data published in The Journal of Allergy and Clinical Immunology.

Use of environmental exposure chambers to test for conjunctivitis response from birch appeared to be closer to natural exposure vs. use of conjunctival allergen challenge, according to data published in Clinical and Translational Allergy.

Deficiencies in the CARMIL2 gene can lead to a variety of immunodeficiency complications, including cutaneous and respiratory allergies, necessitating clinician attention and further research, according to a study published in Allergy.

Three currently available type 2 biologics approved for asthma appeared effective in treating chronic rhinosinusitis with nasal polyps, according to data published in The Journal of Allergy and Clinical Immunology: In Practice.

Researchers used latent class analysis to identify four subgroups of children with allergic rhinitis based on patterns of clinical symptoms and comorbidities, according to a study published in Pediatric Allergy and Immunology.

Greenhouse workers experienced high levels of sensitization to insects and mites used for biological pest control where they work, according to a cross-sectional study published in The Journal of Allergy and Clinical Immunology: In Practice.

Dupilumab improved patient-reported taste compared with placebo among those with chronic rhinosinusitis with nasal polyps, according to study results presented during the European Academy of Allergy and Clinical Immunology Annual Meeting.

Dupilumab effectively treated nasal polyposis with minimal toxicity among treatment-refractory patients in a real-world setting, according to results of a retrospective cohort study published in Annals of Allergy, Asthma & Immunology.

Quality of life for children with allergic conjunctivitis was significantly lower for them and their parents compared with children without it, according to findings published in JAMA Ophthalmology.